UnitedHealth Group Engages with White House Amid DOJ Investigation

UnitedHealth Group, the nation's largest health insurer, is actively engaging with White House officials amid an ongoing Department of Justice (DOJ) investigation into its Medicare Advantage billing practices. The DOJ is examining allegations that UnitedHealth may have inflated patient risk scores to secure higher payments from the government.

In response to the investigation, UnitedHealth has increased its lobbying efforts, doubling its budget in the first half of 2025 to $7.7 million. The company has hired individuals with close ties to the administration, including fundraiser Brian Ballard and former Justice Department official Jesse Panuccio. Additionally, UnitedHealth has replaced its legal team with Robert Giuffra and his team at Sullivan & Cromwell.

UnitedHealth has also sought direct meetings with the president, though such a meeting has not yet occurred. Investors are closely monitoring these developments, concerned about potential policy shifts and stricter billing oversight that could impact the company's financial outlook.

The company has stated its commitment to cooperating with the DOJ and maintaining the integrity of its business practices.

As of September 15, 2025, UnitedHealth Group's stock is trading at $352.51, reflecting a slight decrease of 0.29% from the previous close.